Crossmark

Advancing inclusive healthcare through PBPK modelling: predicting the impact of CYP genotypes and enzyme ontogenies on infant exposures of venlafaxine and its active metabolite O-desmethylvenlafaxine in lactation

Crossref DOI link: https://doi.org/10.1007/s10928-025-09969-4

Published Online: 2025-04-04

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pan, Xian https://orcid.org/0000-0003-2418-5970
Rowland Yeo, Karen https://orcid.org/0000-0002-7020-1970
License Information

Text and Data Mining valid from 2025-04-01

Version of Record valid from 2025-04-04
More Information

Article History

Received: 31 January 2025

Accepted: 19 March 2025

First Online: 4 April 2025

Declarations

:

: K.R.Y. and X.P. are employees of Certara UK Limited, Sheffield, UK and may hold shares in Certara.

Document is current

Any future updates will be listed below